Latest stories

ISO EV pushes AI skin analyzers into global beauty-tech market

ISO EV pushes AI skin analyzers into global beauty-tech market

South Korea's ISO EV is widening its distribution from body composition analyzers to AI-powered 3D skin analyzers, with EVE MUSE and EVE YOUNG targeting clinics, retailers and salons worldwide. The company reports rising exports and new franchise partners across Asia, Europe and the Middle East.

Chimes AI Taps FPT AI Factory GPUs to Speed Industrial GenAI Inference 2.9x

Chimes AI Taps FPT AI Factory GPUs to Speed Industrial GenAI Inference 2.9x

Chimes AI is running its Tukey industrial platform on FPT AI Factory's NVIDIA H100 GPUs, cutting end-to-end inference latency from 9.54 seconds to 3.28 seconds in a 2K-input benchmark. The startup says the collaboration supports its expansion into industrial and manufacturing markets in Vietnam and the region.

Futu Marks 14th Anniversary With HK$300 Million Youth and Research Push

Futu Marks 14th Anniversary With HK$300 Million Youth and Research Push

Futu Holdings has launched the "FUTU NEXT" initiative on its 14th anniversary, committing HK$300 million over five years to Hong Kong university research and youth talent development. The company also signed an intended collaboration MoU with the University of Hong Kong and began preparations for an independent FUTU NEXT Foundation.

Ribo Files EU Clinical Trial Application for Dual-Targeting siRNA SR122 in Dyslipidemia

Ribo Files EU Clinical Trial Application for Dual-Targeting siRNA SR122 in Dyslipidemia

Suzhou Ribo Life Science and subsidiary Ribocure Pharmaceuticals have submitted a Phase I clinical trial application in the EU for SR122, a dual GalNAc conjugated siRNA targeting ApoC3 and PCSK9 for dyslipidemia. The randomized, placebo-controlled study will assess safety, tolerability, pharmacokinetics and pharmacodynamics in healthy participants.